Jan 12, 2022 / 01:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good Morning. I'm happy to kick off day 3 here with Boston Scientific. I'm Robbie Marcus, medtech analyst at JPMorgan. Very happy to introduce Mike Mahoney, the CEO of Boston Scientific. And afterwards in Q&A, we're going to have Dan Brennan and Lauren Tengler join us as well. But with that, Mike, I see you're in San Fran. You're ready to go.
Michael F. Mahoney - Boston Scientific Corporation - Chairman, President & CEO
I am.
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
I'll hand it off to you.
Michael F. Mahoney - Boston Scientific Corporation - Chairman, President & CEO
We're planting the flag in support of your meeting here. Well, thank you, Robbie. As you know, it's a -- we feel honored to help represent Boston Scientific at this JPMorgan conference.
For those who are less familiar with it, it's a very exciting company, very innovative, focused
Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot